4
Changes in Ownership
UroGen Pharma Ltd. Filed Acc 0001415889-24-024932
Options or other derivatives
- Chief Financial Officer acquired 87,592 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Degnan Chris · Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-10-08 | Grant or award : show line 1 in the form Restricted Stock Units | +13,450 | 13,450 | D |
| 2024-10-08 | Grant or award : show line 2 in the form Employee Stock Option (right to buy) | +74,142 | 74,142 | D |
Loading xslF345X05/form4-10092024_081051.xml…